Home > News > Endovasc's CEO to Attend Second Annual Conference
July 20th, 2005
Endovasc's CEO to Attend Second Annual Conference
Abstract:
Endovasc Inc., a business development corporation that pioneers cardiovascular and metabolic drug therapies, announced today that Diane Dottavio, PhD, the Company's President and Chief Executive Officer, will attend the second conference on the topic "Lipids, Liposomes and Biomembranes: New Technologies 2005"
Source:
businesswire
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||